Impact of Checkpoint Inhibitor Immunotherapy, Primarily Pembrolizumab, on Infection Risk in Patients with Advanced Lung Cancer: A Comparative Retrospective Cohort Study

Alexandre E. Malek, Melissa Khalil, Ray Hachem, Anne Marie Chaftari, Johny Fares, Ying Jiang, Dimitrios P. Kontoyiannis, Frank Fossella, Patrick Chaftari, Victor E. Mulanovich, George M. Viola, Issam I. Raad

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Impact of Checkpoint Inhibitor Immunotherapy, Primarily Pembrolizumab, on Infection Risk in Patients with Advanced Lung Cancer: A Comparative Retrospective Cohort Study'. Together they form a unique fingerprint.

Medicine & Life Sciences